Erythropoietin and radiotherapy in lung cancer patients.
Articles > Article · 2009
Authors: V. Yurut-Caloglu, AYFER HAYDAROĞLU, S. Ozkok, Deniz YALMAN, Y. Bolukbasi
Journal of B.U.ON. : official journal of the Balkan Union of Oncology, Journal Indexed in SCI Expanded, International, 2009, vol 14, pp 519-21
Summary
Purpose. To evaluate the effectiveness of recombinant human erythropoietin (rhEPO) in relation to low hemoglobin (Hb) level, overall tumor response rates, and rhEPO adverse events in patients with lung cancer undergoing radiotherapy (RT).